MedTrace Logo

Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease

NCT04505618 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1050

Last updated 2026-03-09

No results posted yet for this study

Summary

This study will perform a prospective, longitudinal analysis of clinical and imaging findings from normal controls and subjects with retinal vascular disease to better define the diagnostic imaging criteria that signify change in disease stage. This includes disease progression in early stages of disease or disease regression with appropriate standard-of-care treatment.

Conditions

Interventions

DEVICE

Swept-Source (SS) OCT Angiography

Non-invasive, minimal risk, ocular imaging study

DEVICE

Spectral-Domain (SD) OCT Angiography

Non-invasive, minimal risk, ocular imaging study

DEVICE

Fundus Imaging

Non-invasive, minimal risk, ocular imaging study

DEVICE

Axial Length Measurement Device

Non-invasive, minimal risk, ocular imaging study

Sponsors & Collaborators

Principal Investigators

  • Amir Kashani, MD, MPH · Johns Hopkins University

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2026-06-01
Completion
2026-09-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04505618 on ClinicalTrials.gov